Year-over-year, this metric grew by 30.2%, from $632.90M to $824.30M. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -28.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $807.30M | $1.29B | $361.30M | $1.10B | $623.60M | $767.60M | $0.00 | $511.70M | $394.80M | $470.00M | $637.30M | $677.70M | $652.50M | $632.90M | $529.90M | $609.30M | $0.00 | $824.30M |
| QoQ Change | — | +59.6% | -72.0% | +205.4% | -43.5% | +23.1% | -100.0% | — | -22.8% | +19.0% | +35.6% | +6.3% | -3.7% | -3.0% | -16.3% | +15.0% | -100.0% | — |
| YoY Change | — | — | — | — | -22.8% | -40.4% | -100.0% | -53.6% | -36.7% | -38.8% | +24.5% | +71.7% | +38.8% | -0.7% | -21.8% | -6.6% | — | +30.2% |